DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of "Moderate Buy" from Brokerages

Key Points

• DocGo Inc. has received a consensus rating of “Moderate Buy” from six research firms, with an average twelve-month target price of $3.59.
• The company reported a quarterly loss of ($0.11) EPS, missing analysts' expectations, but achieved revenue of $80.42 million for the quarter.
• Institutional investors currently hold 56.44% of DocGo's stock, with notable increases in holdings from firms like P.A.W. Capital Corp and S Squared Technology LLC.

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six research firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $3.59.

Separately, Canaccord Genuity Group lifted their price target on shares of DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a research report on Thursday, August 21st.

DocGo Stock Performance

Shares of DCGO opened at $1.56 on Tuesday. The firm has a market cap of $152.58 million, a PE ratio of -8.21 and a beta of 0.97. The firm's 50 day moving average price is $1.53 and its 200 day moving average price is $1.89. DocGo has a twelve month low of $1.23 and a twelve month high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. The firm had revenue of $80.42 million during the quarter, compared to the consensus estimate of $77.58 million. DocGo has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that DocGo will post 0.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DocGo

A number of institutional investors have recently modified their holdings of the company. P.A.W. Capital Corp raised its position in shares of DocGo by 60.0% in the second quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company's stock valued at $5,024,000 after purchasing an additional 1,200,000 shares during the period. S Squared Technology LLC grew its stake in shares of DocGo by 52.2% in the second quarter. S Squared Technology LLC now owns 2,878,286 shares of the company's stock worth $4,519,000 after acquiring an additional 987,310 shares during the last quarter. Punch & Associates Investment Management Inc. grew its stake in shares of DocGo by 17.4% in the first quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock worth $5,812,000 after acquiring an additional 325,760 shares during the last quarter. Jefferies Financial Group Inc. grew its stake in shares of DocGo by 5.7% in the second quarter. Jefferies Financial Group Inc. now owns 2,144,456 shares of the company's stock worth $3,367,000 after acquiring an additional 115,000 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of DocGo by 24.9% in the fourth quarter. Northern Trust Corp now owns 1,606,139 shares of the company's stock worth $6,810,000 after acquiring an additional 320,133 shares during the last quarter. Institutional investors own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.